A modeling study showed that under Canada 's current regime of risk-based screening and treatment, the incidence of, and liver-related deaths would decrease by 79.4%, 76.1%, and 62.1%, respectively, between 2015 and 2030. However, CHC incidence would decrease by only 11.1%.
Similar calculations were made for the incidence of CHC-induced DC, CHC-induced HCC, and other HCV-related health outcomes in Ontario. According to the model, if the aggressive treatment or aggressive screening and treatment strategy were adopted after 2022, the incidence of CHC-induced liver death would drop by 72.6% or 72.9% in 2030, respectively, compared with 2015 levels, thereby meeting WHO's 65% reduction target.
"Clinicians, particularly general practitioners, play an important role in screening and linking patients to care, especially in regions where there is no population screening recommendation in effect," said Wong."I would suggest that clinicians review the risk-based screening guidelines, which are updated periodically. If your patients fall into one of the categories, I recommend a one-time screening and linking them to viral hepatitis care if they test positive for HCV.
HCV - Hepatitis C Virus HCV Hepatitis C (HCV) Hepatitis C Virus (HCV) Hepatitis/Hiv Coinfection HIV Infection HIV Disease HIV Hepatitis Viral Hepatitis Hepatitis A Chronic Hepatitis Canada Canadian Preventive Screening Screening Liver
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Source: physorg_com - 🏆 388. / 55 Read more »
Source: washingtonian - 🏆 74. / 68 Read more »
Source: dothaneagle - 🏆 337. / 59 Read more »
Source: KVUE - 🏆 244. / 63 Read more »
Source: mercnews - 🏆 88. / 68 Read more »